ABC | Volume 114, Nº2, February 2020

Update Update of the Brazilian Guideline on Nuclear Cardiology – 2020 Arq Bras Cardiol. 2020; 114(2):325-429 early adenosine technetium-99m sestamibi myocardial perfusion imaging in identifying a low-risk group for early hospital discharge after acute myocardial infarction. J Am Coll Cardiol. 2006;48(12):2448-57. 64. Kim C, Kwok YS, Heagerty P, Redberg R. Pharmacologic stress testing for coronary disease diagnosis: A meta analysys. Am Heart J. 2001;142(6):934-44. 65. Nair SU, Ahlberg AW, Mathur S, Katten DM, Polk DM, Heller GV. The clinical value of single photon emission computed tomographymyocardial perfusion imaging in cardiac risk stratification of very elderly patients (≥80 years) with suspected coronary artery disease. J Nucl Cardiol. 2012;19(2):244-55. 66. Cerci MS, Cerci JJ, Cerci RJ, Pereira Neto CC, Trindade E, Delbeke D, et al. Myocardial perfusion imaging is a strong predictor of death in women. JACC CVAS Imaging .2011;4(8):880-8. 67. Falcão A, Chalela W, Giorgi MC, Imada R, Soares J Jr, Do Val R, et al. Myocardial Blood flow assessment with 82 rubidium-PET imaging in patients with left bundle branch block. Clinics .2015;70(11):726-32. 68. Fallahi B, Beiki D, Eftekhari M, Gilani KA, Fard-Esfahani A, Gholamrezanezhad A, et al. High accuracy of myocardial perfusion imaging in patients with left bundle branch block: comparison of four interpretation approaches. Hell J Nucl Med. 2009;12(2):132-7. 69. Bokhari S, Ficaro EP, McCallister BD Jr. Adenosine stress protocols for myocardial perfusion imaging. J Nucl Cardiol. 2007;14(3):415-6. 70. Center for Science in the Public Interest. Caffeine content of food & drugs. 2014.Table containing the caffeine content of food and drugs. [Internet]. [Cited in 2017 Dec 12]. Available from: http://www.cspinet . org/new/cafchart.htm. 71. Lette J, Tatum JL, Fraser S, Miller DD, Waters DD, Heller G, et al. Safety of dipyridamole testing in 73,806 patients: The multicenter dipyridamole safety study. J Nucl Cardiol. 1995;2(1):3-17. 72. Iskandrian AE, Bateman TM, Belardinelli L, Blackburn B, Cerqueira MD, Hendel RC, et al: Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: Results of the ADVANCE phase 3 multicenter international trial. J Nucl Cardiol. 2007;14(5):645-58. 73. Geleijnse ML, Elhendy A, Fioretti PM, Roelandt JR. Dobutamine stress myocardial perfusion imaging. J Am Coll Cardiol. 2000;36(7):2017-27. 74. Miller DD: Physiologic and pharmacologic stressors. InDilsizian V, Narula J, Braunwald E, (eds): Atlas of Nuclear Cardiology. 4th ed. New York: Springer. 2013. p. 111-44. 75. Issa A, De Lorenzo A, Oliveira B, Pellini M, Lima R. Comparison between accelerated and conventional dobutamine stress protocols for myocardial perfusion scintigraphy. Int J Cardiovasc Imaging. 2012;28(7):1823-8. 76. Nkoulou R, Wolfrum M, Pazhenkottil AP, Fiechter M, Buechel RR, Gaemperli O, et al. Gated SPECT myocardial perfusion imaging with cadmium-zinc-telluride detectors allows real-time assessment of dobutamine-stress-induced wall motion abnormalities. J Nucl Cardiol. 2018 Jan 6 [Epub ahead print]. 77. Vitola JV, Brambatti JC, Caligaris F, Lesse CR, Nogueira PR, Joaquim AI, et al. Exercise supplementation to dipyridamole prevents hypotension, improves electrocardiogram sensitivity and increases heart-to-liver ratio on Tc-99m sestamibi imaging. J Nucl Cardiol. 2001. 8(6):652-9. 78. Iskandrian AE, Bateman TM, Belardinelli L, Blackburn B, Cerqueira MD, Hendel RC, et al; ADVANCE MPI Investigators. Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial. J Nucl Cardiol. 2007;14(5):645-58. 79. Dilsizian V, Gewirtz H, Paivanas N, Kitsiou AN, Hage FG, Crone NE, et al. Serious and potentially life-threatening complications of cardiac stress testing: Physiological mechanisms and management strategies. J Nucl Cardiol. 2015;22(6):1198-213. 80. Gould KL, Lipscomb K. Effects of coronary stenoses on coronary flow reserve and resistance. Am J Cardiol. 1974;34(1):48-55. 81. JohnsonNP, Kirkeeide RL, Gould KL. same lesion, different artery, different FFR!? JACC Cardiovasc Imaging. 2018; S1936-878X (17)31154-3. 82. Johnson NP, Gould LK. Fractional flow reserve returns to its origins. quantitative cardiac positron emission tomography. Circ Cardiovasc Imaging. 2016;9(9):e005435. 83. Zimmermann FM, Ferrara A, Johnson NP, van Nunen LX, Escaned J, Albertsson P, et al. Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial. Eur Heart J. 2015; 36(45):3182–8. 84. van Nunen LX, Zimmermann FM, Tonino PA, Barbato E, Baumbach A, EngstrømT, et al; FAME Study Investigators. Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomized controlled trial. Lancet. 2015;386(10006):1853-1860 85. De Bruyne B, Fearon WF, Pijls NH, Barbato E, Tonino P, Piroth Z, et al; FAME 2 Trial Investigators. Fractional flow reserve-guided PCI for stable coronary artery disease. N Engl J Med. 2014;371(13):1208-17. 86. Johnson NP, Tóth GG, Lai D, Zhu H, Açar G, Agostoni P, et al. Prognostic value of fractional flow reserve: linking physiologic severity to clinical outcomes. J Am Coll Cardiol. 2014;64(16):1641-54. 87. Mustafa SJ, Morrison RR, Teng B, Pelleg A. Adenosine receptors and the heart: role in regulation of coronary blood flow and cardiac electrophysiology. Handb Exp Pharmacol. 2009;(193):161-88. 88. Chan SY, Brunken RC, Czernin J, Porenta G, KuhleW, Krivokapich J, et al. Comparison of maximal myocardial blood flowduring adenosine infusion with that of intravenous dipyridamole in normal men. J Am Coll Cardiol. 1992;20(4):979-85. 89. Chareonthaitawee P, Askew JW, Heller GV, Downey BC. Overviewof stress radionuclide myocardial perfusion imaging. UpToDate, 2018. [Cited in 2018 Dec 15]. Available from: https://www.uptodate.com/contents/ overview-of-stress-radionuclide-myocardial-perfusion-imaging. 90. Lima RS, Watson DD, Goode AR, Siadaty MS, Ragosta M, Beller GA, et al. Incremental value of combined perfusion and function over perfusion alonebygatedSPECTmyocardialperfusion imaging fordetectionofsevere three-vessel coronary artery disease. J AmColl Cardiol. 2003;42(1):64-70.  91. Marwick TH, Shaw LJ, Lauer MS, Kesler K, Hachamovitch R, Heller GV, et al.Thenoninvasivepredictionofcardiacmortality inmenandwomenwith known or suspected coronary artery disease. Economics of Noninvasive Diagnosis (END) Study Group. Am J Med. 1999;106(2):172-8. 92. Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, Cabico JA, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death andmyocardial infarction. Circulation. 1998;97(6):535-43. Errata em: Circulation. 1998;98(2):190. 93. Brown KA. Prognostic value of thallium-201myocardial perfusion imaging. A diagnostic tool comes of age. Circulation. 1991;83(2):363-81. 94. Bateman TM, O'Keefe JH Jr, Dong VM, Barnhart C, Ligon RW. Coronary angiographic rates after stress single-photon emission computed tomographic scintigraphy. J Nucl Cardiol. 1995;2(3):217-23. 95. MillerTD,ChristianTF,HodgeDO,MullanBP,GibbonsRJ.Prognosticvalue of exercise thallium-201 imaging performed within 2 years of coronary artery bypass graft surgery. J Am Coll Cardiol. 1998;31(4):848-54. 96. Eagle KA, Rihal CS, Mickel MC, Holmes DR, Foster ED, Gersh BJ. Cardiac risk of noncardiac surgery: influence of coronary disease and type of surgery in 3368 operations. CASS investigators and university of michigan heart care program. Coronary Artery Surgery Study. Circulation. 1997;96(6):1882-7. 97. Udelson,JE,Dilsizian,V,BonowRO.NuclearCardiology.Molecular imaging of the cardiovascular system. In: Mann DL, Zipes DP, Libby P, Bonow RO, Braunwald’s E, (eds). 10th ed. Philadelphia: Elsevier;2015. p.311-315. 98. Ottenhof MJ, Wai MC, Boiten HJ, Korbee RS, Valkema R, van Domburg RT, Schinkel AF. 12-Year outcome after normal myocardial perfusion 414